These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2617200)

  • 1. Cancer in inflammatory bowel disease.
    Gyde SN
    Scand J Gastroenterol Suppl; 1989; 170():79-80; discussion 79-80. PubMed ID: 2617200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of cancer in inflammatory bowel disease: why are the results in the reviewed literature so varied?
    Hordijk ML; Shivananda S
    Scand J Gastroenterol Suppl; 1989; 170():70-4; discussion 81-2. PubMed ID: 2694348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of inflammatory bowel disease.
    Burisch J; Munkholm P
    Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire.
    Moody GA; Jayanthi V; Probert CS; Mac Kay H; Mayberry JF
    Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1179-83. PubMed ID: 8980937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent Advances in Understanding Colorectal Cancer and Dysplasia Related to Ulcerative Colitis].
    Yang DH
    Korean J Gastroenterol; 2015 Dec; 66(6):312-9. PubMed ID: 26691188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and incidence of colorectal cancer in patients with ulcerative colitis in Funen county diagnosed between 1973 and 1993.
    Wandall EP; Damkier P; Møller Pedersen F; Wilson B; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 2000 Mar; 35(3):312-7. PubMed ID: 10766327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.
    Velayos FS; Loftus EV; Jess T; Harmsen WS; Bida J; Zinsmeister AR; Tremaine WJ; Sandborn WJ
    Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk in ulcerative colitis.
    Farmer RG
    Scand J Gastroenterol Suppl; 1989; 170():75-7; discussion 81-2. PubMed ID: 2617198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis.
    Loftus EV
    Gastroenterol Clin North Am; 2006 Sep; 35(3):517-31. PubMed ID: 16952738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer.
    Desai D; Shah S; Deshmukh A; Abraham P; Joshi A; Gupta T; Deshpande R; Khandagale V; George S
    World J Gastroenterol; 2015 Mar; 21(12):3644-9. PubMed ID: 25834332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric inflammatory bowel disease during a 44-year period in Copenhagen County: occurrence, course and prognosis--a population-based study from the Danish Crohn Colitis Database.
    Jakobsen C; Paerregaard A; Munkholm P; Wewer V
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1291-301. PubMed ID: 19581873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
    Jess T; Riis L; Vind I; Winther KV; Borg S; Binder V; Langholz E; Thomsen OØ; Munkholm P
    Inflamm Bowel Dis; 2007 Apr; 13(4):481-9. PubMed ID: 17206705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of colonic cancer in inflammatory bowel disease.
    Binder V
    Scand J Gastroenterol Suppl; 1989; 170():78; discussion 81-2. PubMed ID: 2617199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis.
    Castaño-Milla C; Chaparro M; Gisbert JP
    Aliment Pharmacol Ther; 2014 Apr; 39(7):645-59. PubMed ID: 24612141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: low risk of colorectal cancer in a Greek cohort of inflammatory bowel disease patients.
    Kountouras J; Zavos C; Chatzopoulos D; Polyzos SA; Deretzi G; Simeonidou C; Grigoriadis N; Vardaka E; Kountouras C; Loli E; Moschos J; Kouklakis G; Katsinelos P
    Aliment Pharmacol Ther; 2014 May; 39(9):1001-2. PubMed ID: 24689353
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory bowel disease and its association with colorectal cancer.
    Schechter S
    R I Med; 1995 Jun; 78(6):161-3. PubMed ID: 7626814
    [No Abstract]   [Full Text] [Related]  

  • 18. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Gurbuz AK; Giardiello FM; Bayless TM
    Dis Colon Rectum; 1995 Jan; 38(1):37-41. PubMed ID: 7813342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.
    Dulai PS; Sandborn WJ; Gupta S
    Cancer Prev Res (Phila); 2016 Dec; 9(12):887-894. PubMed ID: 27679553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.